KATHERINE CARTER: Open Payments
NPI 1255652590 · BUNKIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 20 payments from 12 companies in 2025. Trend: 2023 $1,460 · 2024 $1,493 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| PFIZER INC. | 2 | $27 |
| Kestra Medical Technology Services, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| ABIOMED | 1 | $21 |
| Itamar Medical Inc | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: LEQVIO, VERQUVO, ELIQUIS, Assure WCD, DIAMONDBACK CORONARY, CAPVAXIVE, WatchPATONE, OPSUMIT.
Industry payments across LA — which companies pay providers there.
